This session provides a brief background on the science of pharmacogenomics and applications in cardiovascular, psychiatry, and pain management. Brief case scenarios are presented to illustrate pharmacogenetic-guided medication therapy. Ethical, legal, social, and economic challenges of translating pharmacogenomics into clinical practice are discussed.
Contact hours available until 10/3/2017.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, Authors, and Speakers Conflict of Interest Disclosure: Faculty, planners, authors, and speakers have no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity has been co-provided by Anthony J. Jannetti, Inc. and GAPNA.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number, CEP 5387.
Objectives: 1. Define the science of pharmacogenomics and briefly review the lessons from the Human Genome Project. 2. Demonstrate an understanding of the variability in the genetic polymorphisms for the pivotal CYP450 liver enzymes and some drug transporters. 3. Discuss the potential impact of pharmacogenetics as a tool in therapeutic clinical decision-making for medication management utilizing a few mini case scenarios. 4. Enumerate the challenges (ethical, legal, and social implications) facing the wide application of pharmacogenetic testing.